BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 34718336)

  • 1. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
    Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
    Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
    Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
    Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miR-3180-3p inhibits proliferation and metastasis of non-small cell lung cancer by downregulating FOXP4.
    Chen T; Liu Y; Chen J; Zheng H; Chen Q; Zhao J
    Thorac Cancer; 2021 Feb; 12(3):372-381. PubMed ID: 33350095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
    Fan JM; Zheng ZR; Zeng YM; Chen XY
    Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy.
    Ma Y; Yuwen D; Chen J; Zheng B; Gao J; Fan M; Xue W; Wang Y; Li W; Shu Y; Xu Q; Shen Y
    Int J Nanomedicine; 2019; 14():8121-8132. PubMed ID: 31632022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X; Liu D; Peng G; Liu J; Yang H
    Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p.
    Wei F; Ma C; Zhou T; Dong X; Luo Q; Geng L; Ding L; Zhang Y; Zhang L; Li N; Li Y; Liu Y
    Mol Cancer; 2017 Jul; 16(1):132. PubMed ID: 28743280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
    Ren P; Gong F; Zhang Y; Jiang J; Zhang H
    Tumour Biol; 2016 Mar; 37(3):3215-25. PubMed ID: 26432332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMSCs-Derived Exosomal MiR-126-3p Inhibits the Viability of NSCLC Cells by Targeting PTPN9.
    Chen J; Ding C; Yang X; Zhao J
    J BUON; 2021; 26(5):1832-1841. PubMed ID: 34761590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29b-3p targetedly regulates VEGF to inhibit tumor progression and cisplatin resistance through Nrf2/HO-1 signaling pathway in non-small cell lung cancer.
    Sun Z; Ren M; Niu J; Tang G; Li Y; Kong F; Song X
    Environ Toxicol; 2024 Jul; 39(7):3956-3966. PubMed ID: 38587027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
    Wang A; Wang J
    DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p.
    Chen QF; Kong JL; Zou SC; Gao H; Wang F; Qin SM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7408-7418. PubMed ID: 31539128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.
    Ding Z; Zhu J; Zeng Y; Du W; Zhang Y; Tang H; Zheng Y; Qin H; Liu Z; Huang JA
    Mol Carcinog; 2019 Jun; 58(6):1019-1032. PubMed ID: 30811684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.